Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Artificial APC Expressing membranous anti-CD3 mAb, CD80, and CD83 expand CD8+ and CD4+ T lymphocytes but not FOXP3+ regulatory T cells

Artificial APC Expressing membranous anti-CD3 mAb, CD80, and CD83 expand CD8+ and CD4+ T lymphocytes but not FOXP3+ regulatory T cells. Tumor Immunology: An Integrated Perspective, AACR Special Conference. 2006.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.